the antiarrhythmic efficacy of intravenous flecainide and intravenous digoxin was assessed in 29 patients ( 26 men ) , aged 43 to 73 ( 63 +/- 7 ) years who developed atrial arrhythmias in the first 96 hours after coronary artery bypass grafting .
C0003195
antiarrhythmic
C0016229
flecainide